Pharmaceutical Technology Europe
October 01, 2012
Manufacturing
24
10
Key considerations for outsourcing energy services.
October 01, 2012
Ingredients
24
10
The physical form of an API is an important consideration in formulation development. Particle-engineering technologies, such as crystal design for controlling crystallisation and producing cocrystals, particle-size reduction and amorphous solid dispersions, help to optimise delivery of a drug.
October 01, 2012
Industry Insider
24
10
EMA has been increasing its interactions with other regulatory agencies across the globe. The agency's most talked about collaboration is with FDA, but EMA has also been intently focused on bolstering its relationship with its counterparts in Japan, India and Russia.
October 01, 2012
Issue PDF
24
10
Click the title above to open the Pharmaceutical Technology Europe October 2012 issue in an interactive PDF format.